Neurocrine Biosciences (NBIX) Change in Inventory: 2017-2021
Historic Change in Inventory for Neurocrine Biosciences (NBIX) over the last 4 years, with Dec 2021 value amounting to $5.0 million.
- Neurocrine Biosciences' Change in Inventory fell 31.51% to $5.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $2.5 million, marking a year-over-year decrease of 76.64%. This contributed to the annual value of $19.1 million for FY2024, which is 453.70% up from last year.
- As of Q4 2021, Neurocrine Biosciences' Change in Inventory stood at $5.0 million, which was up 278.57% from -$2.8 million recorded in Q3 2021.
- Over the past 5 years, Neurocrine Biosciences' Change in Inventory peaked at $7.3 million during Q4 2020, and registered a low of -$2.8 million during Q3 2021.
- Moreover, its 3-year median value for Change in Inventory was $1.3 million (2019), whereas its average is $1.6 million.
- Per our database at Business Quant, Neurocrine Biosciences' Change in Inventory surged by 1,697.05% in 2019 and then slumped by 325.00% in 2021.
- Quarterly analysis of 5 years shows Neurocrine Biosciences' Change in Inventory stood at $782,000 in 2017, then crashed by 152.05% to -$407,000 in 2018, then skyrocketed by 1,697.05% to $6.5 million in 2019, then grew by 12.31% to $7.3 million in 2020, then plummeted by 31.51% to $5.0 million in 2021.
- Its Change in Inventory stands at $5.0 million for Q4 2021, versus -$2.8 million for Q3 2021 and -$1.8 million for Q2 2021.